PCI Biotech: Invitation to first half 2025 results presentation and corporate update
PCI Biotech: Invitation to first half 2025 results presentation and corporate update
Oslo, Norway, 26 August 2025 - PCI Biotech (OSE: PCIB) invites to a webcast
presentation of the company's first half 2025 interim report on Friday, 29
August 2025, 08:30am - 09:00am CET (local time).
The presentation will be held in Norwegian as a live webcast available through
www.pcibiotech.com.
There will be a Q&A session at the end of the presentation. Please submit
questions to [email protected] (mailto:[email protected]) prior to the
webcast. It will be possible to post written questions through the webcast
console during the session.
The interim report and presentation will be made available on www.newsweb.no and
on the company's webpage, www.pcibiotech.com, from 07.00am CET the same day.
For further information, please contact:
Ronny Skuggedal, CEO / CFO
Email: [email protected]
Mobile: +47 9400 5757
For further information, please visit: www.pcibiotech.com
Contact information: PCI Biotech Holding ASA, Ullernchausséen 64, N-0379
Oslo
Forward-looking statements
This announcement may contain forward-looking statements, which as such are not
historical facts, but are based upon various assumptions, many of which are
based, in turn, upon further assumptions. These assumptions are inherently
subject to significant known and unknown risks, uncertainties and other
important factors. Such risks, uncertainties, contingencies and other important
factors could cause actual events to differ materially from the expectations
expressed or implied in this announcement by such forward-looking statements.
PCI Biotech disclaims any obligation to update or revise any forward-looking
statements, whether as a result of new information, future events or otherwise.
This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.